| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/05/2001 | CN1070490C 吲哚衍生物 Indole derivatives |
| 09/05/2001 | CN1070489C Process for synthesis of substituted sulphoxides |
| 09/05/2001 | CN1070480C 2-amino-benzoxanones for treatment of viral infections |
| 09/05/2001 | CN1070379C Medicine for regulating human body functions, and process for producing same |
| 09/05/2001 | CN1070373C Health-care oral liquid-contg. the fruit of Chinese wolfberry and prepn. method therefor |
| 09/05/2001 | CN1070370C Crystalline amifostine compositions and process for prepn. of same and use thereof |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284918 Selective inhibitors of prostaglandin endoperoxide synthase-2 |
| 09/04/2001 | US6284887 Process for preparing carboxamido-4-azasteroids |
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284880 A dna molecule coding for a gene that has anti-apoptotic effects; for transfection of eukaryotic cells without toxic effects |
| 09/04/2001 | US6284872 Tendon-inducing compositions |
| 09/04/2001 | US6284790 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same |
| 09/04/2001 | US6284784 2-hydroxymethyl derivatives |
| 09/04/2001 | US6284780 Prevent tumor necrosis factor retrovirus reproduction |
| 09/04/2001 | US6284777 Carbohydrazide protease inhibitors |
| 09/04/2001 | US6284776 Method for treating diseased-related or drug-induced dyskinesias |
| 09/04/2001 | US6284773 Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2 |
| 09/04/2001 | US6284770 Administering serotonine receptor antagonist |
| 09/04/2001 | US6284769 Nonpeptide kappa opioid receptor antagonists |
| 09/04/2001 | US6284768 Src family SH2 domain inhibitors |
| 09/04/2001 | US6284767 Retroviral protease inhibiting compounds |
| 09/04/2001 | US6284764 Antiproliferative agent |
| 09/04/2001 | US6284760 Method of treating schizophrenia, depression and other neurological conditions |
| 09/04/2001 | US6284757 Antiserotinone agent |
| 09/04/2001 | US6284751 Carpal tunnel syndrome; adult respiatory suystem disorders; antitumor agents |
| 09/04/2001 | US6284743 Method for modulating smooth muscle cell proliferation |
| 09/04/2001 | US6284741 Genetic engineered nucleic acid |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284731 Polypeptides |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284538 Oligonucleotide used for diabetes and cancer treatment |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284242 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 09/04/2001 | US6282837 Methods of controlling the growth of undesired vegetation with herbicide tolerant plants or plant seeds having altered protoporphyrinogen oxidase activity |
| 09/04/2001 | CA2125103C 6-piperazinyl-1h-pyrazolo¬3,4-b|pyridine-3-carboxylic acids, esters, amides and related compounds, a process for their preparation and their use as medicaments |
| 08/30/2001 | WO2001063267A1 Method of screening compounds for biological activity |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062901A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | WO2001062800A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062776A1 Hla binding peptides and their uses |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062769A1 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 08/30/2001 | WO2001062765A2 Small molecule modulators of g protein-coupled receptor six |
| 08/30/2001 | WO2001062763A1 Method for inhibiting trypsin-type serine proteases |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062756A1 Pyridinylimidazoles |
| 08/30/2001 | WO2001062751A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 08/30/2001 | WO2001062750A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 08/30/2001 | WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062725A2 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | WO2001062721A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062717A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | WO2001062715A1 Novel cd23 inhibitors |
| 08/30/2001 | WO2001062714A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062713A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062705A2 Aminoalcohol derivatives |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062668A2 Sulfur containing compounds |
| 08/30/2001 | WO2001062341A2 Combination product for the treatment of obesity |
| 08/30/2001 | WO2001062300A2 Caspase activated prodrugs therapy |
| 08/30/2001 | WO2001062295A1 Drugs containing combined active ingredients |
| 08/30/2001 | WO2001062294A1 Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062293A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062292A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062289A2 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/30/2001 | WO2001062288A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062262A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 08/30/2001 | WO2001062261A1 Metalloproteinase inhibitors for the treatment of respiratory diseases |
| 08/30/2001 | WO2001062257A2 Bupropion metabolites and methods of their synthesis and use |
| 08/30/2001 | WO2001062255A1 Antiviral azaindole derivatives |
| 08/30/2001 | WO2001062252A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062251A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062239A2 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | WO2001062234A2 Dosing regimen |
| 08/30/2001 | WO2001062233A2 Adenosine receptor modulators |
| 08/30/2001 | WO2001062223A2 Cosmetic preparations containing plant extracts |
| 08/30/2001 | WO2001062213A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same |
| 08/30/2001 | WO2001025248A3 Design of high affinity rnase h recruiting oligonucleotide |
| 08/30/2001 | WO2001013031A3 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 08/30/2001 | WO2001012823A3 Macular degeneration diagnostics and therapeutics |
| 08/30/2001 | WO2001012606A3 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/30/2001 | WO2001012195A3 Use of morphine derivatives as medicaments for the treatment of neuropathic problems |
| 08/30/2001 | WO2001012127A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 08/30/2001 | WO2001010457A3 Pharmaceutical compositions containing tripeptides |